AI Science Tracker

AI-guided natural-product-inspired molecules inhibit two multidrug-resistance transporters

Zhejiang University of Technology; Zhejiang–Egypt Joint Laboratory on Intelligent Discovery of Marine Drugs; Zhejiang Provincial People’s Hospital; University of Pittsburgh · 10 Sep 2026 · medicine

Discovery

AI-guided natural-product-inspired molecules inhibit two multidrug-resistance transporters

Combining marine natural-product fragment mining, AI-based molecular generation and structure-guided selection, the authors designed optimized analogues Ib18 and It12 targeting the ABC transporters P-glycoprotein (ABCB1) and BCRP (ABCG2). Both analogues reversed transporter-mediated resistance in overexpressing cells and outperformed reference inhibitors. Target-engagement assays supported transporter inhibition without expression downregulation. In xenografts, Ib18 increased mitoxantrone antitumor activity and tumor accumulation without a detected increase in systemic toxicity.

Technology: AI-based molecular generation integrated with marine natural-product fragment mining and structure-guided prioritization

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Target-engagement assays supported transporter inhibition without expression downregulation.
  • Still unknown: The evidence is cellular and preclinical xenograft evidence, not patient efficacy or established clinical safety. The abstract reports no systemic toxicity increase in the studied xenograft setting, which should not be generalized. It does not give quantitative potency values or detailed comparator identities in the abstract.
  • AI role: AI-based generation contributed candidates to a natural-product-inspired library; structure-guided prioritization selected optimized analogues for synthesis and functional tests. The authors tested Ib18 and It12 in transporter-overexpressing cells and evaluated Ib18 with mitoxantrone in xenografts.

Evidence sources: https://pubmed.ncbi.nlm.nih.gov/42720471/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.